ÂÜÀòÂÒÂ×

Dr. Briggs Morrison brings with him over 25 years of leadership experience. Morrison served as Chief Executive Officer of Syndax Pharmaceuticals and as a member of the company’s board of directors since 2015. He also currently serves as a managing director of MPM Capital, a healthcare-focused venture capital firm, since June 2015. Prior to joining Syndax Pharmaceuticals and MPM Capital, Dr. Morrison held several leadership positions at AstraZeneca, Pfizer and Merck, overseeing the development of numerous biopharmaceutical products in multiple therapeutic areas, from first-in-human trials through to global regulatory approvals. He is also a board member of the Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit organization dedicated to optimizing the global clinical research system.